Search
Citations & References (2)
Thermo Scientific™
Formic Acid, LC-MS Grade
Thermo Scientific Formic Acid is high-purity solvent supplied in bottles as a convenient, contamination-free alternative for preparing elution solvents forRead more
| Catalog Number | Quantity |
|---|---|
| 28905 | 10 x 1 mL |
Catalog number 28905
Price (KRW)
173,000
Each
Quantity:
10 x 1 mL
Price (KRW)
173,000
Each
Thermo Scientific Formic Acid is high-purity solvent supplied in bottles as a convenient, contamination-free alternative for preparing elution solvents for HPLC separations of protein and peptides.
General properties of formic acid
• Molecular formula: HCOOH (CH2O2)
• Molecular weight: 46.02
• Density: 1.22 g/mL
• CAS number: 64-18-6
• Refractive index: 1.3701–1.3721(20°C)
• Flash point: 69°C
• Freezing point: 8°C
Specifications of Thermo Scientific Formic Acid
• Visual: Clear liquid, free of particulate matter
• Identity (IR): Must show only peaks characteristic for the compound
• Purity: > 99%
• Refractive index: 1.3701 to 1.3721 (20°C, 589 nm)
Formic Acid is specially purified and tested to the highest specifications to ensure the integrity of your data, maximize sensitivity in your assay and to prolong the life of your equipment.
Formic acid is a common component of reverse-phase mobile phases that provide protons for LC/MS analysis. The presence of a low concentration of formic acid in the mobile phase is also known to improve the peak shapes of the resulting separation. Unlike trifluoroacetic acid (TFA), formic acid is not an ion-pairing agent and it does not suppress MS ionization of polypeptides when used as a mobile-phase component.
General properties of formic acid
• Molecular formula: HCOOH (CH2O2)
• Molecular weight: 46.02
• Density: 1.22 g/mL
• CAS number: 64-18-6
• Refractive index: 1.3701–1.3721(20°C)
• Flash point: 69°C
• Freezing point: 8°C
Specifications of Thermo Scientific Formic Acid
• Visual: Clear liquid, free of particulate matter
• Identity (IR): Must show only peaks characteristic for the compound
• Purity: > 99%
• Refractive index: 1.3701 to 1.3721 (20°C, 589 nm)
Formic Acid is specially purified and tested to the highest specifications to ensure the integrity of your data, maximize sensitivity in your assay and to prolong the life of your equipment.
Formic acid is a common component of reverse-phase mobile phases that provide protons for LC/MS analysis. The presence of a low concentration of formic acid in the mobile phase is also known to improve the peak shapes of the resulting separation. Unlike trifluoroacetic acid (TFA), formic acid is not an ion-pairing agent and it does not suppress MS ionization of polypeptides when used as a mobile-phase component.
For Research Use Only. Not for use in diagnostic procedures.
Specifications
For Use WithHPLC, Mass Spectrometry
FormLiquid
Item NameFormic Acid
Product LinePierce
Quantity10 x 1 mL
Reagent TypeSolvent (Pure)
Unit SizeEach
Contents & Storage
Store in original container protected from direct sunlight in a dry, cool and well-ventilated area.
Citations & References (2)
Citations & References
Abstract
Improved therapeutic efficacy in two mouse models of methylmalonic acidemia (MMA) using a second-generation mRNA therapy.
Journal:Molecular genetics and metabolism
PubMed ID:39121792
Isolated methylmalonic acidemia/aciduria (MMA) due to MMUT enzyme deficiency is an ultra-rare pediatric disease with high morbidity and mortality, with no approved disease-altering therapies. Previous publications showed that systemic treatment with a codon-optimized mRNA encoding wild-type human MMUT (MMUT) is a promising strategy for treatment of MMA. We developed a
Protocol for identifying metabolite biomarkers in patient uterine fluid for early ovarian cancer detection.
Journal:STAR protocols
PubMed ID:38489270
High mortality of ovarian cancer (OC) is primarily attributed to the lack of effective early detection methods. Uterine fluid, pooling molecules from neighboring ovaries, presents an organ-specific advantage over conventional blood samples. Here, we present a protocol for identifying metabolite biomarkers in uterine fluid for early OC detection. We describe